Windlas Biotech Limited (WINDLAS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.49B |
| Enterprise Value | 15.83B |
| P/E Ratio | 35.59 |
| PEG Ratio | 19.46 |
| Price/Sales Ratio | 2.54 |
| Price/Book Ratio | 4.01 |
| Enterprise/Revenue | 2.54 |
| Enterprise/EBITDA | 20.35 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 9.04B |
| Revenue/Share | 456.53 |
| Gross Profit | 1.64B |
| EBITDA | 1.05B |
| Net Income | 664.56M |
| Diluted EPS | 31.15 |
Balance Sheet
| Total Cash | 2.79B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 281.47 |
Price History
| 52-Week Change | 13.71 |
| 52-Week High | 1,181.9 |
| 52-Week Low | 697.4 |
| Moving Average 50 Days | 930.4 |
| Moving Average 200 Days | 832.57 |
Statistics
| Average Volume | 138,800 |
| Shares Outstanding | 21.17M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.3 |
| Trailing Annual Dividend Yield | 0.56 |
| Payout Ratio | 0.18 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
